Back to Search
Start Over
A phase I/II study of ASKB589 (anti-claudin 18.2 [CLDN18.2] monoclonal antibody) in patients with solid tumors.
- Source :
- Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p397-397, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 41
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 161484863
- Full Text :
- https://doi.org/10.1200/JCO.2023.41.4_suppl.397